Many bipolar affective disorder (BD) susceptibility loci have been identified but the molecular mechanisms responsible for the disease remain to be elucidated. In the locus 4p16, several candidate genes were identified but none of them was definitively shown to be associated with BD. In this region, the PPP2R2C gene encodes the Bg-regulatory subunit of the protein phosphatase 2A (PP2A-Bg). First, we identified, in two different populations, single nucleotide polymorphisms and risk haplotypes for this gene that are associated to BD. Then, we used the Bg subunit as bait to screen a human brain cDNA library with the yeast two-hybrid technique. This led us to two new splice variants of KCNQ2 channels and to the KCNQ2 channel itself. This unusual K þ channel has particularly interesting functional properties and belongs to a channel family that is already known to be implicated in several other monogenic diseases. In one of the BD populations, we also found a genetic association between the KCNQ2 gene and BD. We show that KCNQ2 splice variants differ from native channels by their shortened C-terminal sequences and are unique as they are active and exert a dominant-negative effect on KCNQ2 wild-type (wt) channel activity. We also show that the PP2A-Bg subunit significantly increases the current generated by KCNQ2wt, a channel normally inhibited by phosphorylation. The kinase glycogen synthase kinase 3 beta (GSK3b) is considered as an interesting target of lithium, the classical drug used in BD. GSK3b phosphorylates the KCNQ2 channel and this phosphorylation is decreased by Li þ .
Many bipolar affective disorder (BD) susceptibility loci have been identified but the molecular mechanisms responsible for the disease remain to be elucidated. In the locus 4p16, several candidate genes were identified but none of them was definitively shown to be associated with BD. In this region, the PPP2R2C gene encodes the Bg-regulatory subunit of the protein phosphatase 2A (PP2A-Bg). First, we identified, in two different populations, single nucleotide polymorphisms and risk haplotypes for this gene that are associated to BD. Then, we used the Bg subunit as bait to screen a human brain cDNA library with the yeast two-hybrid technique. This led us to two new splice variants of KCNQ2 channels and to the KCNQ2 channel itself. This unusual K þ channel has particularly interesting functional properties and belongs to a channel family that is already known to be implicated in several other monogenic diseases. In one of the BD populations, we also found a genetic association between the KCNQ2 gene and BD. We show that KCNQ2 splice variants differ from native channels by their shortened C-terminal sequences and are unique as they are active and exert a dominant-negative effect on KCNQ2 wild-type (wt) channel activity. We also show that the PP2A-Bg subunit significantly increases the current generated by KCNQ2wt, a channel normally inhibited by phosphorylation. The kinase glycogen synthase kinase 3 beta (GSK3b) is considered as an interesting target of lithium, the classical drug used in BD. GSK3b phosphorylates the KCNQ2 channel and this phosphorylation is decreased by Li Introduction Bipolar affective disorder (BD) is a common psychiatric disease which afflicts 0.5-1.5% of the world population irrespective of the culture and geographical origin. 1 It is mainly characterized by episodes of mania and/or hypomania interspersed with periods of depression. Heritability of BD is well documented and a number of susceptibility loci have been identified on several chromosomes but, up to date, no specific genes were found. Among these regions we retained the 4p16 locus since significant linkage with BD was found in Scottish, Danish and American pedigrees. [2] [3] [4] [5] A recent study on Faroese population confirmed the link between this locus and BD and schizophrenia. 6 The 4p16 region encodes several interesting candidate genes such as ADRA2C (a-adrenergic receptor 2C), WFS1 (wolframin; heterozygous carriers display an estimated 26-fold increased incidence of psychiatric illness 7 ) or DRD5 (dopamine D5 receptor) genes.
Nevertheless, none of them has been definitively proven to participate in BD. [8] [9] [10] [11] Thus, we tested a region around the WFS1 gene for genetic association with BD by case/control single nucleotide polymorphism (SNP) markers association study. We found that SNPs in the PPP2R2C gene are associated with BD. Interestingly the microsatellite marker D4S431 located within this gene is the telomeric mark of a D4S431-D4S403 region where Blackwood et al. 2 originally observed the occurrence of the maximum lod score in a Scottish pedigree.
The PPP2R2C gene encodes the Bg regulatory subunit of protein phosphatase 2A (PP2A-Bg). The expression pattern of this subunit is brain and neuron specific, 12 where, as other regulatory subunits, it acts by targeting specific substrates to the PP2A core enzyme. This enzyme is associated with phosphorylation-dephosphorylation processes which, when they do not operate properly, might easily lead to neuronal diseases. 13, 14 It was thus important to identify proteins associated with PP2A-Bg, and eventually link the genetic data to a functional hypothesis. This type of strategy has previously been used to identify candidate genes and their partners in schizophrenia. 15 Among the different partners identified to interact with PP2A-Bg, the present study identifies and describes the KCNQ2 potassium channel and two new splice variants. The interest for this particular partner of PP2A-Bg was guided by the following reasons (i) KCNQ2 channel activity is dependent on its state of phosphorylation, 16 (ii) dysfunction of ionic channels associated with pathologies 17 has been observed for several members of the KCNQ family, particularly mutations in KCNQ2 channels are responsible for a peculiar form of epilepsy called benign familial neonatal convulsions (BFNC), 18, 19 (iii) a genetic association study indicates that KCNQ2 gene is also linked to BD in one of the two populations we used.
Results
Genetic analysis for PP2A-Bg subunit Four SNP markers have been developed in the PPP2R2C gene and genotyped in two independent collections of BD patients from Argentina and UK. We have shown that these markers follow the Hardy-Weinberg conditions of gametic equilibrium. Allelic and genotypic P-values were calculated for these markers with traditional w 2 statistics and we considered results with P-values o5 Â 10 À2 as nominally significant. We found that all four SNPs are associated with BD (Table 1 , significant data in bold). SNP 99-24169/139 is associated with BD in the UCL collection (significant allelic and genotypic P-values), while SNPs 24-257/320 and 99-24175/218 are associated in the Labimo collection (significant allelic P-values). In addition, 99-24175/218 and 24-247/ 216 are also associated with BD in the UCL collection with a significant genotypic P-value (Table 1) .
In order to determine if there is a combination of SNPs that presents a higher risk of developing the disease, we performed a haplotype analysis for 24- Identification of novel isoforms of the KCNQ2 voltage-gated potassium channel by yeast two-hybrid screening With the aim of identifying new protein targets of the PP2A-Bg subunit with a functional link to BD, we screened an adult human brain cDNA library with the yeast two-hybrid (Y2H) system using a bait constructed with the full-length cDNA of the PPP2R2C gene. We screened 1.2 Â 10 7 yeast transformants of the cDNA library. We analyzed a total of 494 DNA sequences among which 122 code for 43 independent genes (Supplementary information, Table 7 ). Seven identified genes coded for cytoskeletal or related proteins such as MAP1A LC2, MAP1B LC1, tubulin b4, b-actin, SCG10/stathmin 2, flotillin-1 or dynein light chain A. The nature and functions of these putative partners corresponded to the cytoskeletal localization of PP2A-Bg subunit and consequently, validate the reliability of the Y2H screen. Three other clones coding for proteins involved in the control of the cellular electrical activity have been identified. They correspond to the b1 subunit of the Na þ /K þ adenosine triphosphate (ATP)ase, the synaptosomal-associated protein 25 and the KCNQ2 K þ channel. We focused our attention on two independent clones (3H2 and 3H9) which were of particular interest because they both correspond to partial polyadenylated cDNAs encoding new splice variants of the intracytoplasmic domain of the voltage-gated potassium channel KCNQ2.
An alignment of the longest clone 3H2 with the genomic sequence of KCNQ2, showed that it corresponds to fulllength exons 12-14, and to the unspliced intron 14 according to the nomenclature of Biervert and Steinlein. 20 Despite the lack of intron 14 splicing-out, this latter remains in frame with exon 14, over 55 amino-acid residues. The new encoded intracytoplasmic domain, although shorter than that of the canonical KCNQ2 isoform 1 (KCNQ2 wild type (wt)), 19 presents a complete A-domain and a large part of the B-domain described as essential for channel functionality 21 ( Figure 1a and Supplementary information, Figure 1a ). Real-time polymerase chain reaction (PCR) performed on human brain cDNAs indicates that splice variant mRNAs represent about 10% of wt channel mRNAs (Supplementary information, Figure 1b) .
Mating experiments were duplicated and, using the same bait, we again isolated 3H2 and 3H9 clones, confirming the relevance of the interaction detected during the initial Y2H screen.
Genetic analysis for KCNQ2
In order to strengthen the relevance of the implication of the KCNQ2 channel in BD, we calculated the genetic association of the KCNQ2 gene with bipolar disease by case/control SNP markers association study. Six SNPs located in the KCNQ2 gene were found from Celera data bank and genotyped in the two independent collections of BD previously used for the PPP2R2C genetic study. No association was found in the Argentinian Labimo collection whatever the SNP tested. Nonetheless, two SNPs, 30-2/62 and 30-7/30, within the KCNQ2 gene are significantly associated with BD in the UCL collection ( Table 2 ). More specifically, 30-2/62 was found to be highly associated with BD in this collection, with both significant allelic and genotypic P-values ( Table 2 ). The risk genotype for 30-2/62 is 'AG' and that for 30-7/30 is 'CC'. The significant genotypic odds ratios for 30-2/62 are 1.62 (AG versus (GG þ AA)) and 1.82 ((AG þ AA) versus GG). For the 30-7/30 marker they are of 1.58 and 1.71 for (CC versus TT) and (CC versus (TT þ CT)) respectively (Supplementary information, Table 6 ). The association results of the single biallelic marker frequency analysis show that the KCNQ2 gene is associated with BD. These results validate the hypothesis of a molecular interaction between PP2A-Bg -regulatory subunit and KCNQ2 channels, consequently, a dysfunction and/or a dysregulation of these channels, associated or not with PP2A-Bg dysfunction, may contribute to the onset and development of BD.
Interaction domain mapping of the 3H2 and KCNQ2wt products. Using mating test experiments we have characterized the domains necessary for the interaction between KCNQ2 channels that is wt and clone 3H2, and the PP2A-Bg subunit ( Figure 1a ). We found that the 55 amino acids encoded by the unspliced intron 14 of KCNQ2 were not necessary for the interaction between the 3H2 product and the PP2A-Bg subunit. Only the 158 amino residues encoded by exons 12-14 are responsible for the association. Amino acids of exon 14, spanning the junction between the A-and Bdomains, are crucial for binding as their removal totally abolished the occurrence of colonies on the most stringent selective medium. The association of the PP2A-Bg regulatory subunit with the product of the 3H2 clone was further tested in stably transfected HEK-293 cells overexpressing pHM6-PPP2R2C (HEK-293-PP2A-Bg), coding for a N-terminal HA-tagged version of PP2A-Bg subunit. The GST-3H2 peptide precipitated a protein that was detected by anti-HA antibodies and with a size corresponding to the tagged version of PP2A-Bg subunit (Figure 1c) . No PP2A-Bg protein was precipitated by GST alone.
Both in vitro assays and ex vivo precipitation experiments confirmed the relevance of the interaction identified in vivo by the Y2H system.
Cloning of two full-length cDNAs corresponding to the new splice variant isoform of the voltage-gated potassium channel KCNQ2 Full-length cDNAs encoding the new KCNQ2 splice variants were isolated from reverse transcription-polymerase chain reactions performed with human brain thalamus polyA þ mRNA and specific primers of both 3H2 clone and KCNQ2wt. Two cDNAs, hereafter called Q2-3H2 and Q2-3H9, respectively 1933 and 1879 bp long, were entirely sequenced. Q2-3H9 cDNA differs from Q2-3H2 only by the absence of exon 11. Owing to the lack of intron 14 splicingout the intracytoplasmic domains of both Q2-3H2 and Q2-3H9 are shorter (331 and 313 amino residues, respectively) than that of KCNQ2wt (560 amino residues) ( Figure 1a and Supplementary information, Figure 1a) . No clones corresponding to another unspliced intron were found among numerous clones we sequenced, arguing against cloning artifacts for both Q2-3H2 and Q2-3H9 splice variants. Figures 2A and 4) . The apparent decrease of cell surface expression in nonpermeabilized cells is also observed with KCNQ2wt V5-tagged channels (Figure 2Ac,d) .
Homo or heteromeric associations are a necessary property of the KCNQ family to be expressed at the cellular membrane. 21, 22 These interactions take place in the Cterminal part of channels. We checked, using GST pull-down technique, that both variants were able to homomerize and heteromultimerize with wt channels (Supplementary information, Figures 2B and 5) .
Taken together these experiments indicate that the new splice variant isoforms are correctly expressed at the cell membrane and are able to form heteromultimers with the KCNQ2wt channel, two necessary criteria for channel activity.
COS cell expression of KCNQ2wt and splice variant channels
The whole cell patch-clamp technique was used to record currents from transfected cells, the CD8 antigen was used as a transfection reporter. We found that 100% of CD8-positive cells expressed the KCNQ2wt channel, that only 10% of CD8-positive cells also expressed the Q2-3H2 channel and surprisingly, that 0% expressed the Q2-3H9 channel (Figure To check that these differences were not due to the cell line used, we repeated these experiments in the CHO cell line and in Xenopus oocytes and we obtained very similar results (data not shown). 3H2 mutant kinetics were faster than those of the wt channel ( Figure 2C ), 100-180 versus 250-700 ms and 50-120 versus 200-400 ms for activation and deactivation kinetics, respectively. Activation curves were not significatively different since the voltage to obtain 50% of activation (V 0.5 ) remains in the same range towards À20 mV (Supplementary information, Figure 6 ).
Cotransfection of KCNQ2wt with either Q2-3H2 or Q2-3H9 splice variants resulted in the absence of measurable currents ( Figure 2D ) indicating the dominant-negative effect of splice variants on wt channel activity. These data were confirmed in Xenopus oocyte experiments (data not shown).
The possible interaction of Q2-3H2 or Q2-3H9 with the KCNQ3 channel (the KCNQ2 M-type channel partner) was also tested in Xenopus oocytes. We found that both splice variants are without effect on KCNQ3 channel activity (Supplementary information, Figure 7 ).
Functional effects of PP2A-Bg expression on the KCNQ2 channel activity Since the interaction between PP2A-Bg and KCNQ2 channels (wt and splice variants) was demonstrated in vitro, we decided to analyze the potential functional role of such an association. We transfected the K þ channels in the PP2A-Bg-HEK cells and compared results with those obtained after transfection in wt-HEK cells. Despite its high affinity observed in Y2H experiments, PP2A-Bg had no effect on the Q2-3H2 splice variant activity. Current density values were 1774 and 1573 pA/pF in PP2A-Bg-and wt-HEK cells, respectively (Figure 3) . Conversely, PP2A-Bg increased by a factor of about two the current generated by the KCNQ2wt. 
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Current density values were 8879 and 4575 pA/pF in PP2A-Bg and wt-HEK cells, respectively (Figure 3 ). These functional results confirm the interaction observed in GST pull-down experiments.
A possible explanation of these results is that in HEK cells KCNQ2 channels are mostly present in a hyperphosphorylated/inactive state. 23 Thus, increasing the level of PP2A-Bg subunit, and consequently phosphatase activity, would be expected to lead to an increase of the channel activity.
The glycogen synthase kinase 3 beta kinase phosphorylates the intracytoplasmic domain of KCNQ2 Because Li þ is an important drug in the treatment of BD and because one of the possible Li þ targets in mental disorders is the glycogen synthase kinase 3 beta (GSK3b) (Figure 4a) , 24, 25 we decided to check whether this particular kinase phosphorylates the channel. GSK3b is a peculiar serine/threonine kinase as it needs a prior phosphorylation by another protein kinase of another Ser or Thr residue at position þ 4 in order to be active. 26 Among kinases that were previously described to modulate the KCNQ2 activity, 16, 27 we chose protein kinase A (PKA) as companion kinase. There are putative GSK3b phosphorylation sites (Supplementary information, Figure 1a ) that are common to KCNQ2wt and to its splice variant discovered in this work. We chose the GST-3H2 construct to perform the phosphorylation assays. A band corresponding to the molecular weight of the GST-3H2 fusion protein was detected and only detected in the case of a synergistic phosphorylation by PKA and GSK3b ( Figure  4b ). GST alone was not radiolabelled (Figure 4b ). Moreover, this phosphorylation was completely inhibited by addition of either a phospho-CREB-competitive substrate or by whole cell extracts prepared from the human glioblastoma/astrocytoma U-87 MG cell line which contain large amounts of phosphatase activity, including PP2A. This extract lost its efficacy in the presence of okadaic acid, a potent inhibitor of both protein phosphatases 1 and 2A (Figure 4b and Supplementary information, Figure 8 ). Lithium also partially inhibited GST-3H2 protein phosphorylation (Figure 4b and Supplementary information, Figure 9 ). Nevertheless, while lithium has no effect on KCNQ2wt expressed in HEKwt cells (Figure 3) , we showed that, in PP2A-Bg-HEK cells, the KCNQ2wt current (which is increased as compared with the corresponding current in wt cells, see above), is increased by about 50% after lithium treatment (current density values were 136719 pA/pF, Figure 3) . Lithium is without effect on Q2-3H2 channel activity in wt or PP2A-Bg cells (Figure 3) .
Discussion
Among the loci that are genetically linked to BD, the chromosomal 4p16 region is found in several extended pedigrees (our data, 5, 28 ). We focused on the PPP2R2C gene that encodes the brain-specific PP2A-Bg regulatory subunit. 12, 29 Using case/control genetic association study in two different populations of bipolar patients, we found that individual SNPs and risk haplotypes in PPP2R2C gene are 30 To understand how the PPP2R2C gene might be implicated in the pathology, we searched for interacting proteins by performing a Y2H screening of a human brain cDNA library with the PP2A-Bg subunit as a bait. Among positive clones, we focused our attention on two new splice variants of brain-specific KCNQ2 channels, 18, 31 Q2-3H2 and Q2-3H9. As these splice variants were both identified in two separate cDNA libraries, a cloning artifact can be excluded. No precise localization of the PP2A-Bg subunit in human brain is available, however, the rat and mouse brain PP2A-Bg subunit is found expressed in the same areas as the KCNQ2 channel. 12, [32] [33] [34] The choice of KCNQ2, among other potentially interacting proteins, was motivated in part by the fact that the KCNQ channel family is of particular importance in human K þ channelopathies. Among the 10 K þ channel genes that have been associated with human genetic diseases, four belong to the KCNQ subfamily. 35, 36 Mutations in KCNQ2, but also in KCNQ3 that can form heteromeric association with KCNQ2, are responsible for the same epileptic disorder, BFNC. 37, 38 Owing to their slow deactivation kinetics, M-type channels act as 'damping' components that prevent neuronal hyperactivity. A reduction by only 25% of KCNQ2/KCNQ3 currents is enough to reach an epileptogenic level. 27 Interestingly, a susceptibility locus for BD was recently identified on chromosome 8q24, a region that contains the KCNQ3 gene. 39 We tested the effects of Q2-3H2 or Q2-3H9 on KCNQ3 channel activity and we found that currents generated by the channel are unchanged in the presence of either of the splice variants (Supplementary information, Figure 7 ). These data indicate that these proteins probably do not interact. This observation is not surprising since the C-terminal domain of the channels are responsible for the KCNQ2/KCNQ3 heteromerization in Mtype channels and this domain is not only shortened, but also different in the splice variants. Nevertheless, the identification of the KCNQ3 gene as a susceptibility locus for BD adds weight to the idea that the M-type channel (KCNQ2/KCNQ3) and its regulation might be involved in this disease.
The direct interaction between PP2A-Bg and KCNQ2 variants was definitively established by GST pull-down and solid-phase overlay experiments. However, KCNQ2wt also associates with PP2A-Bg as demonstrated by GST pull-down experiments. This interaction may be less tight that the interaction with KCNQ2 variants as it was not detected in the Y2H screening. Moreover, we performed genetic association study for the KCNQ2 gene itself. Results show, at least in the UCL collection previously used for the PPP2R2C study, that two SNPs in the KCNQ2 gene are associated to BD.
When expressed in mammalian cells, Q2-3H2 produces a current that resembles the wt current; however, activation and deactivation kinetics are three-to fivefold faster for the splice variants. Both Q2-3H2 and Q2-3H9 act as dominantnegative subunits for the expression of KCNQ2wt. Q2-3H2 and Q2-3H9 are unique among the number of described KCNQ2 splice variants, 31, 40 in generating a K þ current, but also exerting a dominant-negative effect. Splice variants identified in this work, because of their faster deactivation kinetics can only control the shape and duration of single action potentials. They cannot prevent the occurrence of fast bursts of action potentials. These properties associated with their dominant-negative effects on the wt KCNQ2 should be expected to confer a hyperexcitability to neurons where they are expressed. An increased excitability of neurons is a characteristic of manic and/or hypomanic periods of BD. 41 A recent report 42 has shown that the suppression of M channels with a KCNQ2 dominantnegative form not only results in a hyperexcitability of neurons and morphological changes of some brain structures, mainly hippocampus, but interestingly, also a decline of cognitive processes and behavioral changes corresponding to hyperactivity.
42
KCNQ2 expression is dependent on phosphorylation state. When phosphorylated, the channel becomes inactive, while dephosphorylation increases its activity. Different kinases such as PKA 27 or PKC 16 are involved in the phosphorylation process, but little is known about the mechanism of dephosphorylation. Electrophysiological experiments show that, in HEK cells, PP2A-Bg increases the KCNQ2wt current amplitude (Figure 3 ). Since in HEK cells, KCNQ2 preferentially exists in a phosphorylated/inactive state, 23 these results suggest that PP2A, via its Bg-regulatory subunit stimulates the dephosphorylation of KCNQ2wt, and then increases channel activity. This current increase is not observed with the Q2-3H2-spliced isoform suggesting, in this case, a regulation pathway different from that of the wt channel. Presently, the nature of dysfunctions (exaggerated or decreased expression and/or activity) affecting the KCNQ2wt, KCNQ2 splice variants and the PP2A (via its Bg subunit) in BD onset or development is not clear.
Lithium is the most commonly used drug in the treatment of BD. 43 Figure 4a shows the different steps at which Li þ can be expected to interfere with activity and regulation of the KCNQ2 channel. First, Li þ inhibits several cellular enzymes involved in inositol recycling, a crucial step in the synthesis of the PIP2, 43 a membrane phospholipid that is essential for KCNQ2 activity and for its regulation by acetylcholine as well as by other neurotransmitters and peptides. [44] [45] [46] Li þ by interfering with this pathway of regulation will necessarily interfere with KCNQ2 activity either basic or regulated by neurotransmitters such as acetylcholine acting on the M1 receptor. Second, the kinase GSK3b has also been shown to be inhibited by Li þ 43,47 and we have shown in this paper that GSK3b can, in vitro, phosphorylate KCNQ2 and that this phosphorylation is decreased by Li þ . Furthermore, we show that a lithium treatment works in synergy with the PP2A-Bg subunit to increase the KCNQ2wt current, indicating that Li þ also alters phosphorylation of the channel probably by inhibiting the endogenous GSK3b activity. Additionally, Li þ PP2A-Bc and KCNQ2 in bipolar disease M Borsotto et al has no effect on splice variant activity which could be related to the lack of efficacy of the lithium treatment in a significant number of patients. 43 In summary, our results suggest that a dysfunction of the KCNQ2-PP2A-Bg subunit regulation pathway and/or a dysfunction in the KCNQ2/KCNQ2 splice variant expression and association might be responsible for changes in neuronal excitability that underline the manic and the depressive episodes occurring in BD. It would be particularly important to determine whether individuals who displayed BFNC in their early childhood are more prone to BD as adults. Seizures in these individuals usually start around day 3 post-natal and disappear in 85-90% of the patients after a few months and only 10-15% of the patients display seizures later in childhood. 18 Both results presented in this work for KCNQ2 and recent data implicating KCNQ3 39 that can also be mutated in BFNC 38 plead for the interest of such a clinical investigation.
The most important conclusion of this work is that it points to the KCNQ2 channel, and its splice variants, as potentially interesting therapeutical targets. The pharmacology of this particular channel type has already started to be investigated as the channel might also be of interest in neuropathic pain, 48 epilepsy 49, 50 and to improve memory. 42 
Materials and methods
Genetic analysis
The possible association of PP2A with bipolar disorder was analyzed in two different populations. One sample was provided by Hospital Pinero, Buenos-Aires, Argentina (the 'Labimo' collection). The other sample was provided by the University College of London (the 'UCL' collection). Both collections are composed of patients affected by bipolar disease according to DSM-IV criteria, and their matched healthy controls. Drug-abusing patients were excluded. Two hundred and six DNA samples from unrelated patients suffering from bipolar disorder and 201 DNA control samples were collected from the Labimo collection, for genotyping analysis. Three hundred and fifteen and 300 DNA samples were analyzed from the UCL collection.
Genotyping of affected and control individuals was obtained by scanning the DNA sample from all individuals in order to establish the allele frequencies of biallelic markers. Thus, we determined the frequencies of every biallelic marker in each population (cases and controls) performing microsequencing reactions on amplified fragments obtained by genomic PCR performed on the DNA samples from each individual.
A detailed experimental procedure for genetic analysis is given in on-line Supplementary information.
Materials
Marathon-Ready human brain cDNA library and human brain thalamus polyA þ RNA were from BD Biosciences (Pont-de-Claix, France) Quick change site-directed mutagenesis kit was from Stratagene (Amsterdam, The Netherlands).
Y2H screening and yeast mating tests
The Saccharomyces cerevisiae AH109 strain was transformed with pGBKT7 plasmid (BD Biosciences) containing the 1644 bp cDNA (genbank accession number: AF086924) of the PPP2R2C gene according to the manufacturer's instructions (Matchmaker Two-Hybrid system, BD Biosciences). Cells expressing the bait were then mixed with a pretransformed Matchmaker human brain cDNA library in the Y187 strain. Three independent matings were performed with, respectively, 5 Â 10 6 , 5Â 10 6 and 2 Â 10 5 clones of the human brain cDNA library. The resulting diploid cells able to grow on SD/-Leu/-Trp medium containing plates were further selected onto the medium-stringency SD/-Leu/-Trp/-His-selective medium for the identification of bait-prey interactions. Positive colonies were then plated onto the high-stringency SD/-Leu/-Trp/-His/-Adeselective medium. Only cDNA of colonies able to grow at the same time on both media were retained for further studies
In vitro or ex vivo GST pull-down assay In vitro binding assays with GST-3H2, GST-KCNQ2wtC-ter and GST-PPP2R2C fusion proteins were performed essentially as described in Cavarec et al. 51 The pGBKT7-3H2 and pGBKT7-PPP2R2C plasmids were in vitro transcribed and translated (TNT T7 Quick coupled transcription/translation system, Promega, Charbonnieres-Les-Bains, France) in the presence of L-[ In vitro phosphorylation assay with recombinant GSK3b kinase and dephosphorylation with U-87 MG whole cell extracts Beads with bound fusion proteins were washed three times in NETN buffer (120 mM NaCl, 1 mM EDTA, 20 mM TrisHCl, pH 8.0 and 0.5% Nonidet P-40) and once in HMK buffer without dithiothreitol (DTT) (20 mM Tris-HCl, pH 7.5, 120 mM NaCl, 12 mM MgCl 2 ). Beads were resuspended in 240 ml of reaction mix (1 Â HMK buffer with 20 mM DTT, 40 U of PKA catalytic subunit, 250 U/vial (Sigma, SaintQuentin-Fallavier, France), in 40 mM DTT, 5 mM ATP) and incubated for 30 min at room temperature. Beads were then washed three times in NETN buffer and once in GSKbreaction buffer, resuspended in 50 ml of reaction mix (1 Â GSK3b reaction buffer, 10 mCi of [ 32 P] g ATP, 50 U of recombinant GSK3b (New England Biolabs, Ozyme, Saint-Quentinen-Yvelines, France) and incubated at room temperature for 30 min with 25 mM LiCl. In competition experiments 2.5 mg of CREB phosphopeptides (New England Biolabs) were added to the kination mix. After three washes in NETN buffer, phosphorylated proteins were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and visualized by autoradiography.
In dephosphorylation assays the in vitro phosphorylated GST-3H2 fusion protein was incubated at room temperature for 30 min with 500 mg of whole cell extracts of the U-87 MG human glioblastoma cell line (ATCC number: HTB-14) with or without 400 nM of the PP2A phosphatase inhibitor okadaic acid (Sigma). Phosphorylated proteins were resolved on 10% SDS-PAGE, and visualized by autoradiography.
PP2A-Bc and KCNQ2 in bipolar disease M Borsotto et al Western blot analysis HEK293-H cells were grown in Dulbecco's-modified Eagle's medium medium (Invitrogen, Cergy-Pontoise, France) supplemented with 0.1 mM non-essential amino acids and 10% fetal bovine serum (Invitrogen), and transiently transfected with 20 mg of either pCMV-Myc-Q2-3H9, pCMV-Myc-Q2-3H2, pcDNA3.1( þ )-Q2-3H9-V5 or pcDNA3.1( þ )-Q2-3H2-V5 plasmids per 60 mm dish using the Invitrogen calcium phosphate transfection protocols. Cell lysis performed in the presence of phosphatase inhibitors (1 mM Na 3 VO 4 and 1 mM NaF), and Western blot analyses were carried out as in Cavarec et al. 51 with, as primary antibodies, anti-c-myc 9E10 monoclonal antibodies (working dilution (wd) 1:1000, Roche, Meylan, France), anti-KCNQ2 (N-19) polyclonal antibodies (wd 1:1000, Santa Cruz Biotechnology, Tebu SA, Le Peray-en-Yvelines, France), Anti-V5 monoclonal antibodies (wd 1:1000, Invitrogen), or Anti-HA monoclonal antibodies (wd 1:5000, Sigma).
Immunofluorescence analysis
At 24 h before transfection, HEK293-H cells were seeded onto poly-L-lysine-coated chamber slides (Lab-Tek) at a density of 2.5 Â 10 5 cells per chamber. Cells were transfected with 0.8 mg of the pcDNA3.1( þ )-Q2-3H9-V5 or pcDNA3.1( þ )-Q2-3H2-V5 plasmids using the Lipofectamine 2000 (Invitrogen). After 2 days, cells were fixed for 10 min at room temperature with 4% paraformaldehyde (PAF) in 1 Â phosphate-buffered saline (PBS). Permeabilized cells were obtained with 0.2% Triton X-100 in PBS for 5 min at room temperature. Incubations with 10% normal goat serum and 1% bovine serum albumin Fraction V (Sigma) in PBS containing 0.2% Triton X-100 and 0.02% Na Azide at room temperature for 1 h, were used to block non-specific sites. An anti-V5 fluorescein isothiocyanate (FITC) antibody (wd 1/200, Invitrogen) was used to detect tagged channels. After washes, cells were mounted in Prolong Antifade Kit reagent (Molecular Probes, Invitrogen, Cergy-Pontoise, France) containing 4 0 -6-diamidino-2-phenylindole (DAPI) (Sigma) at 200 ng/ml and observed by direct phase microscopy (Leica DMRXA, Leica microsystems, Rueil-Malmaison, France). Images were captured with a dual mode cooled CCD camera (Hamamatsu, Massy, France).
Electrophysiological measurements
Cells were seeded in 35 mm diameter Petri dishes at a density of 20 000 cells/dish for COS-7 cells and of 40 000 cells/dish for CHO and HEK-293 cells, 24 h prior to transfection. COS-7 cells were transfected using the classical DEAE-dextran method, CHO cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol and HEK-293 cells using the calcium phosphate transfection protocol. Typically, per 35 mm Petri dish, 1 mg of KCNQ2wt or 1.5 mg of splice channel and 2 mg of GSK3b constructs were co-transfected. Cells were tested 24-48 h after transfection using the whole-cell configuration of the patch-clamp technique. Experiments were carried out at room temperature (20-251C) following the procedure described in Tinel et al. 31 The voltage protocol was constituted by step depolarizations of long duration (2 s) from À60 mV to þ 100 mV (increment 10 mV). The holding potential was maintained at À80 mV.
